J05AE10 • darunavir • Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
Darunavir is a protease inhibitor used for the treatment of human immunodeficiency virus (HIV) infection. It works by inhibiting the HIV protease enzyme, which is essential for viral replication, thereby reducing the viral load.
The medication is taken orally, usually once daily, in combination with other antiretroviral drugs. Common side effects include nausea, diarrhea, headaches, and skin rashes.
Darunavir is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with severe hepatic conditions.
This medication is an important option for managing HIV infection, helping to improve patients' quality of life and prevent disease progression.
Substance: darunavir
Date of last drug list: 01-01-2014
Commercial code: W51827001
Concentration: 300mg
Pharmaceutical form: tablets
Quantity: 120
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).